Clinical Medical Research Center, International University of Health and Welfare, Women's Medical Center, Sanno Medical Center, 8-5-35 Akasaka, Minato-ku, Tokyo, 107-0052, Japan.
Public Health Research Foundation, 1-1-7 Nishiwaseda, Shinjuku-ku, Tokyo, 169-0051, Japan.
J Bone Miner Metab. 2018 Sep;36(5):620-625. doi: 10.1007/s00774-017-0879-7. Epub 2017 Nov 9.
Populations of East Asian countries have been known to have low calcium intakes and low serum 25(OH)D concentrations, suggesting that Ca and vitamin D (VitD)-deficiencies are commonly observed. These nutritional imbalances may lead to low peak bone mass (PBM). The low PBM seen in Ca/VitD-deficient individuals may lead to osteoporosis, as well as an increased risk of fracture. A survey was conducted in young Japanese women (n = 296, 21.2 ± 2.3 years old) on their Ca/VitD intakes and serum 25(OH)D levels, which demonstrated a significant positive correlation between VitD intake and serum 25(OH)D levels (R = 0.020, P = 0.016), and the proportion with serum 25(OH)D over 20 ng/mL was significantly increased with VitD intake (P = 0.013). Serum 25(OH)D was negatively correlated to serum intact parathyroid hormone (R = 0.053, P < 0.001). On receiver operating characteristic curve analysis, the VitD intake threshold for maintaining 25(OH)D levels at 20 ng/mL or higher was 11.6 μg/day or greater. It was suggested that the recommended VitD intake allowance, defined in the Adequate Intakes as 5.5 μg/day, may not be sufficient to maintain serum 25(OH)D levels for bone health.
东亚国家的人群已知钙摄入量低,血清 25(OH)D 浓度低,表明普遍存在钙和维生素 D(VitD)缺乏。这些营养失衡可能导致峰值骨量(PBM)低。在钙/VitD 缺乏个体中观察到的低 PBM 可能导致骨质疏松症,以及骨折风险增加。一项针对年轻日本女性(n=296,21.2±2.3 岁)的钙/VitD 摄入量和血清 25(OH)D 水平的调查显示,VitD 摄入量与血清 25(OH)D 水平之间存在显著正相关(R=0.020,P=0.016),随着 VitD 摄入量的增加,血清 25(OH)D 水平超过 20ng/mL 的比例显著增加(P=0.013)。血清 25(OH)D 与血清完整甲状旁腺激素呈负相关(R=0.053,P<0.001)。在受试者工作特征曲线分析中,维持 25(OH)D 水平在 20ng/mL 或更高的 VitD 摄入量阈值为 11.6μg/天或更高。这表明,建议的 VitD 摄入量允许量(在适宜摄入量中定义为 5.5μg/天)可能不足以维持血清 25(OH)D 水平以促进骨骼健康。